{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:30:53Z","timestamp":1793615453865,"version":"4.5.0"},"reference-count":24,"publisher":"FapUNIFESP (SciELO)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Bras. Parasitol. Vet."],"abstract":"<jats:p>Abstract This study evaluated dynamics of antibodies in dogs treated for canine visceral leishmaniasis (CVL). Twenty-one dogs naturally infected by Leishmania spp. were grouped based on the treatment protocol: G1 (n=4) received allopurinol; G2 (n=10) allopurinol with miltefosine; and G3 (n=7) allopurinol, miltefosine and Leish-Tec\u00ae vaccine. The dogs were monitored monthly for a period of one year. To verify serum antibody titers, an indirect immunofluorescence reaction was performed. We found that dogs from G1 and G2 had lower clinical scores and antibody titers, when compared to the parameters evaluated in pre-treatment; however, clinical relapses were observed in three animals. In G3, clinical scores were lower than pre-treatment; however, they presented relatively stable antibody titers and no clinical relapse was observed. All animals submitted to the evaluated treatment protocols showed relative improvement in clinical signs. Furthermore, the immune response of animals must be considered, given the challenges of parasitic loads in infections. Therefore, it is necessary to complement the methods of clinical and therapeutic monitoring of dogs with CVL in order to establish the risk of transmissibility of the agent in infected and treated dogs.<\/jats:p>","DOI":"10.1590\/s1984-29612025001","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T11:27:28Z","timestamp":1736767648000},"source":"Crossref","is-referenced-by-count":3,"title":["Antibody dynamics in dogs submitted to different canine visceral leishmaniasis treatment protocols"],"prefix":"10.1590","volume":"34","author":[{"given":"Eliesse Pereira","family":"Costa","sequence":"first","affiliation":[{"name":"Universidade Federal de Santa Maria,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele Vaz Aguirre","family":"Samoel","sequence":"additional","affiliation":[{"name":"Universidade Federal de Santa Maria,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilneia da","family":"Rosa","sequence":"additional","affiliation":[{"name":"Universidade Federal de Santa Maria,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Osmari","sequence":"additional","affiliation":[{"name":"Universidade Federal de Santa Maria,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelli Lopes de","family":"Souza","sequence":"additional","affiliation":[{"name":"Universidade Federal de Santa Maria,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Felipe Dias","family":"Lopes","sequence":"additional","affiliation":[{"name":"Universidade Federal de Santa Maria,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Silveira Fl\u00f4res","family":"Vogel","sequence":"additional","affiliation":[{"name":"Universidade Federal de Santa Maria,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f4nia de Avila","family":"Botton","sequence":"additional","affiliation":[{"name":"Universidade Federal de Santa Maria,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2364-1084","authenticated-orcid":false,"given":"Lu\u00eds Ant\u00f4nio","family":"Sangioni","sequence":"additional","affiliation":[{"name":"Universidade Federal de Santa Maria,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"issue":"1","key":"ref1","first-page":"1","article-title":"Use of immunotherapy in the treatment of canine Visceral Leishmaniasis","volume":"48","author":"Ara\u00fajo AKL","year":"2020","journal-title":"Acta Sci Vet"},{"issue":"3","key":"ref2","article-title":"Clinical and parasitological impact of short-term treatment using miltefosine and allopurinol monotherapy or combination therapy in canine visceral leishmaniasis","volume":"31","author":"Ayres ECBS","year":"2022","journal-title":"Rev Bras Parasitol Vet"},{"key":"ref3","article-title":"Portaria Interministerial n\u00ba 1.426, de 11 de 2008. Pro\u00edbe o tratamento de leishmaniose visceral canina com produtos de uso humano ou n\u00e3o registrados no Minist\u00e9rio da Agricultura, Pecu\u00e1ria e Abastecimento","year":"2008","journal-title":"Di\u00e1rio Oficial da Rep\u00fablica Federativa do Brasil"},{"key":"ref4","series-title":"Nota T\u00e9cnica Conjunta n\u00b0 001\/2016 MAPA\/MS","year":"2016"},{"key":"ref5","series-title":"Manual de vigil\u00e2ncia e controle da leishmaniose visceral","year":"2014"},{"key":"ref6","series-title":"Diretrizes para o diagn\u00f3stico, estadiamento, tratamento e preven\u00e7\u00e3o da leishmaniose canina","year":"2018"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00436-022-07654-w","article-title":"Dynamics of Leishmania spp. infection in dogs from an unaffected region in transition to a visceral leishmaniasis transmission area, Rio Grande do Sul, Brazil","volume":"121","author":"de Souza ML","year":"2022","journal-title":"Parasitol Res"},{"key":"ref8","article-title":"Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasis","volume":"217","author":"Dias AFLR","year":"2020","journal-title":"Exp Parasitol"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1111\/tbed.14717","article-title":"Pre\u2010test probability and likelihood ratios for clinical findings in canine leishmaniasis","volume":"69","author":"Gal\u00e1n\u2010Rela\u00f1o \u00c1","year":"2022","journal-title":"Transbound Emerg Dis"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","DOI":"10.1590\/s1984-29612024012","article-title":"Therapeutic success and failure in using miltefosine to treat dogs naturally infected with Leishmania infantum.","volume":"33","author":"Gon\u00e7alves G","year":"2024","journal-title":"Rev Bras Parasitol Vet"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/microorganisms8081201","article-title":"Leishmania Immunity: Advancing Immunotherapy and Vaccine Development","volume":"8","author":"Ikeogu NM","year":"2020","journal-title":"Microorganisms"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0304-4017(01)00399-5","article-title":"A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis","volume":"98","author":"Koutinas AF","year":"2001","journal-title":"Vet Parasitol"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3390\/vaccines11101565","article-title":"Transmission-blocking vaccines for canine visceral leishmaniasis: new progress and yet new challenges","volume":"11","author":"Leite JC","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"ref14","series-title":"Diagn\u00f3stico da Leishmaniose Visceral Canina: Avalia\u00e7\u00e3o do Desempenho dos Kits EIE-Leishmaniose-Visceral-Canina-Bio-Manguinhos e IFI-Leishmaniose-Visceral-Canina-Bio-Manguinhos","author":"Lira RA","year":"2005"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13071-015-0896-0","article-title":"Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol","volume":"8","author":"Manna L","year":"2015","journal-title":"Parasit Vectors"},{"issue":"3-4","key":"ref16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.vetpar.2006.06.028","article-title":"Leishmania DNA load and cytokine expression levels in asymptomatic naturally infected dogs","volume":"142","author":"Manna L","year":"2006","journal-title":"Vet Parasitol"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.tvjl.2008.08.009","article-title":"Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis","volume":"182","author":"Manna L","year":"2009","journal-title":"Vet J"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1007\/s00436-022-07647-9","article-title":"First identification of Lutzomyia longipalpis in an area of visceral leishmaniasis transmission in central Rio Grande do Sul State, southern Brazil","volume":"121","author":"Osmari V","year":"2022","journal-title":"Parasitol Res"},{"issue":"1","key":"ref19","article-title":"Relationship between Leishmania IFAT Titer and Clinicopathological Manifestations (Clinical Score) in dogs","volume":"2014","author":"Proverbio D","year":"2014","journal-title":"BioMed Res Int"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00436-023-07862-y","article-title":"Identification of infection by Leishmania spp. in wild and domestic animals in Brazil: a systematic review with meta-analysis (2001\u20132021)","volume":"122","author":"Ratzlaff FR","year":"2023","journal-title":"Parasitol Res"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1756-3305-4-86","article-title":"LeishVet guidelines for the practical management of canine leishmaniosis","volume":"4","author":"Solano-Gallego L","year":"2011","journal-title":"Parasit Vectors"},{"issue":"43","key":"ref22","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.1016\/j.vaccine.2018.08.087","article-title":"Randomized, controlled, double-blinded field trial to assess Leishmania vaccine effectiveness as immunotherapy for canine leishmaniosis","volume":"36","author":"Toepp A","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006082","article-title":"Canine visceral leishmaniasis: diagnosis and management of the reservoir living among us","volume":"12","author":"Travi BL","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004341","article-title":"Allopurinol resistance in Leishmania infantum from Dogs with disease relapse","volume":"10","author":"Yasur-Landau D","year":"2016","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Revista Brasileira de Parasitologia Veterin\u00e1ria"],"original-title":["Din\u00e2mica de anticorpos em c\u00e3es submetidos a diferentes protocolos de tratamento para leishmaniose visceral canina"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S1984-29612025000100800&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T11:27:35Z","timestamp":1736767655000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1984-29612025000100800&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"alternative-id":["S1984-29612025000100800"],"URL":"https:\/\/doi.org\/10.1590\/s1984-29612025001","relation":{},"ISSN":["1984-2961","0103-846X"],"issn-type":[{"value":"1984-2961","type":"electronic"},{"value":"0103-846X","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e014824"}}